12.50% Gain Drives Nektar Therapeutics (NKTR) Into Becoming A Interest-Loosing Stock For Investors
Nektar Therapeutics (NASDAQ:NKTR) has a beta value of 0.79 and has seen 0.55 million shares traded in the recent trading session. The company, currently valued